Found 10 matching trials
Open-Label, Safety and Superior Effectiveness Study of Cysteamine Bitartrate Delayed-Release Capsules (RP103) in Cystinosis PHASE3 The purpose of this study is to gather information about the effectiveness ...
Show More Location
California Pacific Medical Center (CPMC) Research Institute
Learn More & Join Trial
Long-Term Safety Follow-up Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) PHASE3 Cystinosis is an inherited disease that if untreated, results in kidney fai...
Show More Location
California Pacific Medical Center (CPMC) Research Institute
Learn More & Join Trial
Combination Topical Cysteamine and Fractional 1927nm Low-Powered Diode Laser for Treatment of Facial Melasma NA The primary objective of our study is to determine the efficacy of combined...
Show More Learn More & Join Trial
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease PHASE2 A long-term extension study to assess the safety, tolerability and efficacy...
Show More Location
University of California at San Diego (UCSD)
Learn More & Join Trial
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) PHASE3 Cystadrops® is currently indicated in adults and children from 2 years of a...
Show More Learn More & Join Trial
A Study to Assess TTI-0102 vs Placebo in MELAS Patients PHASE2 This is a randomized, double-blind, placebo-controlled study. Prior to trea...
Show More Location
Angers University Hospital Center (CHU Angers)
Learn More & Join Trial
Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis PHASE3 Cystinosis is an inherited disease that if untreated, results in kidney fai...
Show More Location
Stanford University Medical School
Learn More & Join Trial
A Cohort of Patients With Cystinosis : Compliance to Cysteamine and Neurological Complications NA Preventing late onset of Cystinosis such as neurological complications and ...
Show More Location
Hospices Civils de Lyon
Learn More & Join Trial
Cysteamine Compared to Hydroquinone in Melasma PHASE3 Melasma is an acquired pigmentary disorder of symmetrical hyperpigmentation...
Show More Location
China Medical University Hospital
Learn More & Join Trial
Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis PHASE1 Cystinosis is an inheritable disease that if untreated, results in kidney f...
Show More Location
University of California San Diego Medical Center
Learn More & Join Trial